頭頸部がん（HNC）の世界市場レポート 2025年

頭頸部がん（HNC）市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.8％で29億3,000万米ドルに成長します。予測期間においては、ヘルスケアインフラの拡大、患者の人口動態の上昇、老人人口の増加、医療費の増加、タバコとアルコールの継続的な普及が成長の原動力になると予想されます。予測期間における主な動向としては、免疫療法の進歩、標的治療、技術統合、人工知能（AI）の導入、精密医療の成長などが挙げられます。

タバコの喫煙率の上昇は、頭頸部がん（HNC）市場の成長を促進すると予想されます。タバコの煙を吸ったり吐いたりする喫煙は、さまざまな健康リスクや中毒と関連しています。喫煙率の増加は、ストレス、社会的圧力、積極的なマーケティング、タバコ製品の容易な入手といった要因に影響されることが多いです。HNC医薬品は、タバコの使用によって引き起こされる分子変化を標的とし、それに関連するがんを治療することで、喫煙の有害な影響を緩和するのに役立つと同時に、より良い治療結果を得るためには発がん物質への曝露を減らすことが重要であることを強調しています。例えば、2024年10月に欧州呼吸器学会（ERS）が行った調査では、若者の喫煙率が顕著に増加していることが明らかになり、2022年には22.5％の回答者が喫煙していたのに対し、2024年には40.1％となっています。この喫煙率の上昇がHNC市場の成長を後押ししています。

HNC市場の各社は、治療効果を高め、生存率を向上させ、進行がんの管理におけるアンメット・メディカル・ニーズに対応するため、免疫腫瘍薬などの革新的治療法の開発に注力しています。免疫腫瘍学治療薬は、がん細胞を標的とし、それに対抗するために身体の免疫システムを利用します。これらの治療には、チェックポイント阻害剤、CAR-T細胞療法、がんワクチンが含まれます。例えば、2024年11月、インドの製薬会社ドクター・レディーズ・ラボラトリーズは、上咽頭（のどの上部）に発生するまれな頭頸部がんの成人患者を対象とした免疫腫瘍薬トリパリマブを発表しました。Zytorviとして販売されているこの薬剤は、再発性または転移性の上咽頭がんの治療に使用されます。標準的な化学療法（ゲムシタビンおよびシスプラチン）と併用した場合、進行または死亡のリスクが48％減少することが示されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界頭頸部がん（HNC） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の頭頸部がん（HNC）市場：成長率分析
• 世界の頭頸部がん（HNC）市場の実績：規模と成長, 2019-2024
• 世界の頭頸部がん（HNC）市場の予測：規模と成長, 2024-2029, 2034F
• 世界頭頸部がん（HNC）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の頭頸部がん（HNC）市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 喉頭がん
• 咽頭がん
• 唾液腺がん
• 口唇がんおよび口腔がん
• 鼻咽頭がん
• その他のタイプ
• 世界の頭頸部がん（HNC）市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学療法
• 手術
• 放射線治療
• 標的療法
• その他の治療法
• 世界の頭頸部がん（HNC）市場診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生体検査スクリーニング検査
• 血液検査
• 歯科診断
• 画像診断
• 内視鏡検査
• 世界の頭頸部がん（HNC）市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• eコマース
• 世界の頭頸部がん（HNC）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 外来手術センター
• その他のエンドユーザー
• 世界の頭頸部がん（HNC）市場喉頭がんの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 喉頭上がん
• 声門喉頭がん
• 声門下喉頭がん
• 世界の頭頸部がん（HNC）市場咽頭がんの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 中咽頭がん
• 鼻咽頭がん
• 下咽頭がん
• 世界の頭頸部がん（HNC）市場唾液腺がんの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 耳下腺がん
• 舌下腺がん
• 顎下腺がん
• 小唾液腺がん
• 世界の頭頸部がん（HNC）市場口唇がんおよび口腔がんの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 唇がん
• 頬粘膜がん
• 舌がん
• 歯肉がん
• 口蓋がん
• 世界の頭頸部がん（HNC）市場鼻咽頭がんの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 早期上咽頭がん
• 進行期鼻咽頭がん
• 世界の頭頸部がん（HNC）市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 甲状腺がん
• 食道がん
• 副鼻腔がん

第7章 地域別・国別分析

• 世界の頭頸部がん（HNC）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の頭頸部がん（HNC）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 頭頸部がん（HNC）市場：競合情勢
• 頭頸部がん（HNC）市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthcare Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer Healthcare AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca Plc
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Koninklijke Philips N.V.
• Boehringer Ingelheim
• Fresenius Kabi AG
• Incyte Corporation
• Exelixis Inc.
• Astellas Pharma Inc.
• Rakuten Medical Inc.
• Merus N.V.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 頭頸部がん（HNC）市場2029：新たな機会を提供する国
• 頭頸部がん（HNC）市場2029：新たな機会を提供するセグメント
• 頭頸部がん（HNC）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Head and neck cancer (HNC) encompasses a group of epithelial malignancies that develop in the head and neck region, including the oral cavity, pharynx, larynx, nasal cavity, and salivary glands. The majority of these cancers are squamous cell carcinomas, with major risk factors including tobacco use, alcohol consumption, and human papillomavirus (HPV) infection.

The main types of head and neck cancer (HNC) include laryngeal cancer, pharyngeal cancer, salivary gland cancer, lip and oral cavity cancer, nasopharyngeal cancer, and others. Laryngeal cancer, which develops in the larynx (also known as the voice box), affects functions such as sound production, breathing, and swallowing. Treatment options include chemotherapy, surgery, radiation therapy, targeted therapy, and others. Diagnostic methods include biopsy, screening tests, blood tests, dental diagnosis, imaging, and endoscopy. These diagnostic tools and treatments are distributed through various channels such as hospital pharmacies, retail pharmacies, and e-commerce platforms, and are utilized by different end users such as hospitals, specialty clinics, ambulatory surgical centers, and others.

The head and neck cancer (HNC) market research report is one of a series of new reports from The Business Research Company that provides head and neck cancer (HNC) market statistics, including head and neck cancer (HNC) industry global market size, regional shares, competitors with a head and neck cancer (HNC) market share, detailed head and neck cancer (HNC) market segments, market trends and opportunities, and any further data you may need to thrive in the head and neck cancer (HNC) industry. This head and neck cancer (HNC) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The head and neck cancer (HNC) market size has grown strongly in recent years. It will grow from $2.00 billion in 2024 to $2.17 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth observed in the historic period can be attributed to the increasing incidence of HPV-related cancers, a rise in smoking and alcohol consumption, growing investment in cancer research, heightened awareness and early diagnosis, and an aging population.

The head and neck cancer (HNC) market size is expected to see strong growth in the next few years. It will grow to $2.93 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. In the forecast period, growth is expected to be driven by the expansion of healthcare infrastructure, rising patient demographics, the growing geriatric population, increased healthcare expenditures, and the continued prevalence of tobacco and alcohol use. Key trends in the forecast period include advancements in immunotherapy, targeted therapies, technological integration, the incorporation of artificial intelligence (AI), and the growth of precision medicine.

The rising incidence of cigarette smoking is expected to drive the growth of the head and neck cancer (HNC) market. Cigarette smoking, the act of inhaling and exhaling smoke from burning tobacco, is associated with various health risks and addiction. The increase in smoking rates is often influenced by factors such as stress, social pressures, aggressive marketing, and the easy availability of tobacco products. HNC drugs help mitigate the harmful effects of smoking by targeting molecular changes caused by tobacco use and treating cancers linked to it, while also emphasizing the importance of reducing exposure to carcinogens for better treatment outcomes. For instance, in October 2024, a study by the European Respiratory Society (ERS) revealed a notable increase in smoking among young people, with 22.5% of respondents smoking in 2022 compared to 40.1% in 2024. This rise in smoking rates is driving the growth of the HNC market.

Companies in the HNC market are focused on developing innovative treatments, such as immuno-oncology drugs, to enhance treatment effectiveness, improve survival rates, and address unmet medical needs in managing advanced cancers. Immuno-oncology drugs utilize the body's immune system to target and combat cancer cells. These treatments include checkpoint inhibitors, CAR-T cell therapies, and cancer vaccines. For example, in November 2024, Dr. Reddy's Laboratories, an India-based pharmaceutical company, introduced toripalimab, an immuno-oncology drug for adults with a rare form of head and neck cancer originating in the nasopharynx, the upper part of the throat. This drug, marketed as Zytorvi, is used for treating recurrent or metastatic nasopharyngeal carcinoma. It has shown a 48% reduction in the risk of progression or death when combined with standard chemotherapy (gemcitabine and cisplatin).

In September 2023, Coherus BioSciences, a U.S.-based biopharmaceutical company, acquired Surface Oncology Inc. for an undisclosed amount. This acquisition was aimed at strengthening Coherus' immuno-oncology portfolio by incorporating Surface Oncology's promising drug candidates, including SRF114 and SRF388, which are being developed for various cancers, including head and neck cancer. This move enhances Coherus' competitive position in the oncology market and expands its therapeutic offerings in immunotherapy treatments. Surface Oncology Inc. is a U.S.-based company that specializes in the development of cancer therapies.

Major players in the head and neck cancer (hnc) market are Pfizer Inc., Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer Healthcare AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Koninklijke Philips N.V., Boehringer Ingelheim, Fresenius Kabi AG, Incyte Corporation, Exelixis Inc., Astellas Pharma Inc., Rakuten Medical Inc., Merus N.V.

North America was the largest region in the head and neck cancer (HNC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in head and neck cancer (HNC) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the head and neck cancer (HNC) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The head and neck cancer (HNC) market consists of revenues earned by providing services such as systemic therapy, photodynamic therapy (PDT) and combined modality therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The head and neck cancer (HNC) market also includes sales of targeted therapy drugs, and combination therapy products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Head And Neck Cancer (HNC) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on head and neck cancer (hnc) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for head and neck cancer (hnc) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The head and neck cancer (hnc) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Laryngeal Cancer, Pharyngeal Cancer, Salivary Gland Cancer, Lip And Oral Cavity Cancer, Nasopharyngeal Cancer, Other Types
• 2) By Treatment: Chemotherapy, Surgery, Radiation Therapy, Targeted Therapy, Other Treatments
• 3) By Diagnosis: Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, Endoscopy
• 4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, E-commerce
• 5) By End User: Hospital, Specialty Clinics, Ambulatory Surgical Centers, Other End Users
• Subsegments:
• 1) By Laryngeal Cancer: Supraglottic Laryngeal Cancer; Glottic Laryngeal Cancer; Subglottic Laryngeal Cancer
• 2) By Pharyngeal Cancer: Oropharyngeal Cancer; Nasopharyngeal Cancer; Hypopharyngeal Cancer
• 3) By Salivary Gland Cancer: Parotid Gland Cancer; Sublingual Gland Cancer; Submandibular Gland Cancer; Minor Salivary Gland Cancer
• 4) By Lip And Oral Cavity Cancer: Lip Cancer; Buccal Mucosa Cancer; Tongue Cancer; Gingival Cancer; Palate Cancer
• 5) By Nasopharyngeal Cancer: Early-Stage Nasopharyngeal Cancer; Advanced-Stage Nasopharyngeal Cancer
• 6) By Other Types: Thyroid Cancer; Esophageal Cancer; Sinonasal Cancer
• Companies Mentioned: Pfizer Inc.; Siemens Healthcare Private Limited; F. Hoffmann-La Roche Ltd.; Merck KGaA; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Head And Neck Cancer (HNC) Market Characteristics

3. Head And Neck Cancer (HNC) Market Trends And Strategies

4. Head And Neck Cancer (HNC) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Head And Neck Cancer (HNC) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Head And Neck Cancer (HNC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Head And Neck Cancer (HNC) Market Growth Rate Analysis
• 5.4. Global Head And Neck Cancer (HNC) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Head And Neck Cancer (HNC) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Head And Neck Cancer (HNC) Total Addressable Market (TAM)

6. Head And Neck Cancer (HNC) Market Segmentation

• 6.1. Global Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laryngeal Cancer
• Pharyngeal Cancer
• Salivary Gland Cancer
• Lip And Oral Cavity Cancer
• Nasopharyngeal Cancer
• Other Types
• 6.2. Global Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Surgery
• Radiation Therapy
• Targeted Therapy
• Other Treatments
• 6.3. Global Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioscopy Screening Tests
• Blood Tests
• Dental Diagnosis
• Imaging
• Endoscopy
• 6.4. Global Head And Neck Cancer (HNC) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Pharmacies
• Retail Pharmacies
• E-commerce
• 6.5. Global Head And Neck Cancer (HNC) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Specialty Clinics
• Ambulatory Surgical Centers
• Other End Users
• 6.6. Global Head And Neck Cancer (HNC) Market, Sub-Segmentation Of Laryngeal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Supraglottic Laryngeal Cancer
• Glottic Laryngeal Cancer
• Subglottic Laryngeal Cancer
• 6.7. Global Head And Neck Cancer (HNC) Market, Sub-Segmentation Of Pharyngeal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oropharyngeal Cancer
• Nasopharyngeal Cancer
• Hypopharyngeal Cancer
• 6.8. Global Head And Neck Cancer (HNC) Market, Sub-Segmentation Of Salivary Gland Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parotid Gland Cancer
• Sublingual Gland Cancer
• Submandibular Gland Cancer
• Minor Salivary Gland Cancer
• 6.9. Global Head And Neck Cancer (HNC) Market, Sub-Segmentation Of Lip And Oral Cavity Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lip Cancer
• Buccal Mucosa Cancer
• Tongue Cancer
• Gingival Cancer
• Palate Cancer
• 6.10. Global Head And Neck Cancer (HNC) Market, Sub-Segmentation Of Nasopharyngeal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early-Stage Nasopharyngeal Cancer
• Advanced-Stage Nasopharyngeal Cancer
• 6.11. Global Head And Neck Cancer (HNC) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thyroid Cancer
• Esophageal Cancer
• Sinonasal Cancer

7. Head And Neck Cancer (HNC) Market Regional And Country Analysis

• 7.1. Global Head And Neck Cancer (HNC) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Head And Neck Cancer (HNC) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Head And Neck Cancer (HNC) Market

• 8.1. Asia-Pacific Head And Neck Cancer (HNC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Head And Neck Cancer (HNC) Market

• 9.1. China Head And Neck Cancer (HNC) Market Overview
• 9.2. China Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Head And Neck Cancer (HNC) Market

• 10.1. India Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Head And Neck Cancer (HNC) Market

• 11.1. Japan Head And Neck Cancer (HNC) Market Overview
• 11.2. Japan Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Head And Neck Cancer (HNC) Market

• 12.1. Australia Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Head And Neck Cancer (HNC) Market

• 13.1. Indonesia Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Head And Neck Cancer (HNC) Market

• 14.1. South Korea Head And Neck Cancer (HNC) Market Overview
• 14.2. South Korea Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Head And Neck Cancer (HNC) Market

• 15.1. Western Europe Head And Neck Cancer (HNC) Market Overview
• 15.2. Western Europe Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Head And Neck Cancer (HNC) Market

• 16.1. UK Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Head And Neck Cancer (HNC) Market

• 17.1. Germany Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Head And Neck Cancer (HNC) Market

• 18.1. France Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Head And Neck Cancer (HNC) Market

• 19.1. Italy Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Head And Neck Cancer (HNC) Market

• 20.1. Spain Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Head And Neck Cancer (HNC) Market

• 21.1. Eastern Europe Head And Neck Cancer (HNC) Market Overview
• 21.2. Eastern Europe Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Head And Neck Cancer (HNC) Market

• 22.1. Russia Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Head And Neck Cancer (HNC) Market

• 23.1. North America Head And Neck Cancer (HNC) Market Overview
• 23.2. North America Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Head And Neck Cancer (HNC) Market

• 24.1. USA Head And Neck Cancer (HNC) Market Overview
• 24.2. USA Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Head And Neck Cancer (HNC) Market

• 25.1. Canada Head And Neck Cancer (HNC) Market Overview
• 25.2. Canada Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Head And Neck Cancer (HNC) Market

• 26.1. South America Head And Neck Cancer (HNC) Market Overview
• 26.2. South America Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Head And Neck Cancer (HNC) Market

• 27.1. Brazil Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Head And Neck Cancer (HNC) Market

• 28.1. Middle East Head And Neck Cancer (HNC) Market Overview
• 28.2. Middle East Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Head And Neck Cancer (HNC) Market

• 29.1. Africa Head And Neck Cancer (HNC) Market Overview
• 29.2. Africa Head And Neck Cancer (HNC) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Head And Neck Cancer (HNC) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Head And Neck Cancer (HNC) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Head And Neck Cancer (HNC) Market Competitive Landscape And Company Profiles

• 30.1. Head And Neck Cancer (HNC) Market Competitive Landscape
• 30.2. Head And Neck Cancer (HNC) Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Siemens Healthcare Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Head And Neck Cancer (HNC) Market Other Major And Innovative Companies

• 31.1. Bayer Healthcare AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca Plc
• 31.5. GlaxoSmithKline PLC
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Company
• 31.8. Koninklijke Philips N.V.
• 31.9. Boehringer Ingelheim
• 31.10. Fresenius Kabi AG
• 31.11. Incyte Corporation
• 31.12. Exelixis Inc.
• 31.13. Astellas Pharma Inc.
• 31.14. Rakuten Medical Inc.
• 31.15. Merus N.V.

32. Global Head And Neck Cancer (HNC) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Head And Neck Cancer (HNC) Market

34. Recent Developments In The Head And Neck Cancer (HNC) Market

35. Head And Neck Cancer (HNC) Market High Potential Countries, Segments and Strategies

• 35.1 Head And Neck Cancer (HNC) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Head And Neck Cancer (HNC) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Head And Neck Cancer (HNC) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer